Atai Life Sciences CEO Florian Brand disclosed in a regulatory filing that he had purchased 70,000 shares of company stock at $1.48 per share on March 29, for a total transaction amount of $103,558.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ATAI:
- Rising High: Exclusive talk with multinational cannabis operator Clever Leaves
- atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
- Atai Life Sciences reports Q4 EPS (28c), consensus (23c)
- Here’s What You Missed in Cannabis, Psychedelics This Week
- Rising High: Exclusive talk with house of brands Carma HoldCo